Advanced Biodegradable Colloidal Particle Formulation
Legal Citation
Background and Problem Solved
The original patent disclosed a composite colloidal particle formulation with advanced functionality, comprising an engineered biodegradable particle core dispersed in a bioadhesive polyelectrolyte solution. However, the original invention had limitations in terms of scalability, stability, and biocompatibility. The new invention addresses these limitations by introducing a scalable semi-continuous process, adding stabilizing agents, and surface-modifying the particle core for improved biocompatibility.
Novelty and Inventive Step
The new claims introduce a scalable semi-continuous process, real-time monitoring and control, and improved biocompatibility through surface modification and stabilizing agents, which are not disclosed in the original patent. The combination of these features provides a novel and non-obvious solution to the limitations of the original invention.
Alternative Embodiments and Variations
Alternative embodiments of the invention could include different types of stabilizing agents, surface modifications, and machine learning algorithms. Additionally, the system for large-scale production could be adapted for use with different types of colloidal particle formulations.
Potential Commercial Applications and Market
The invention has potential commercial applications in the pharmaceutical, cosmetic, and biomedical industries, where colloidal particle formulations with advanced functionality are in high demand. The scalable production system and improved biocompatibility features of the invention make it an attractive solution for companies looking to develop and commercialize novel colloidal particle formulations.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A01 | A01N25/22 |
| A | A01 | A01N25/04 |
| A | A01 | A01N25/10 |
| A | A01 | A01N59/20 |
Original Patent Information
| Patent Number | US 11,856,948 |
|---|---|
| Title | Colloidal particle formulations with advanced functionality |
| Assignee(s) | BENANOVA INC. |